Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
Amgen and Astellas pay $125.75 Million to Settle Allegations of Providing…
On April 25, 2019, Astellas Pharma US Inc. (“Astellas”) and Amgen Inc. (“Amgen”) agreed to pay a combined $125.75 million to…
DOJ Hits Three Companies with FCA Settlements for Co-Pay Assistance…
On April 4, 2019, the Department of Justice announced settlements with three different pharmaceutical companies over allegations…
Duke Agrees to Pay $112.5 Million in False Claims Act Settlement Related to…
Late last month, it was announced that Duke University agreed to settle with the Department of Justice (DOJ) a case involving…
DOJ Defends Motion to Dismiss Eleven Qui Tam Suits
A corporation, Health Choice Group, has filed more than a dozen False Claims Act (FCA) lawsuits alleging health care fraud on…
Walgreens to Pay $269.2 To Settle Civil Fraud Lawsuits
The Walgreens Boots Alliance has agreed to pay $269.2 million to settle two separate whistleblower lawsuits accusing it of civil…
300 Drugs Now Under Investigation in “Generic Drug Cartel”
What began at the end of 2016 as an antitrust lawsuit has now exploded into an investigation of alleged price-fixing involving at…
Government Intervenes in Select Few Qui Tam Suits
Mintz Levin recently reviewed unsealed healthcare-related qui tam cases in early 2018, identifying a total of forty-six cases…
AmerisourceBergen Resolves Civil Fraud Charges, Agrees To Pay $625 Million
On Monday, October 1, 2018, the United States Department of Justice (DOJ) announced a $625 million agreement to resolve civil…
AstraZeneca Agrees to Settle Off-Label Marketing Suits
Recently, AstraZeneca Plc agreed to pay $110 million to settle two Texas claims that alleged the company cheated Texas’ Medicaid…
United States Joins Lawsuit Over Suboxone
Recently, the Department of Justice (DOJ) filed to join whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group…